Integra Therapeutics, a global leader in cutting-edge gene writing tools to improve the efficacy, precision and safety of advanced therapies, announced today the appointment of Miles Gerson as the Ind...
The funds come from new investors like the EIC Fund and CDTI Innvierte, as well as from existing investors AdBio Partners, Columbus Venture Partners, Invivo Partners and Takeda Ventures, which continu...
Integra Therapeutics has developed the FiCAT gene-writing platform to develop cell therapies for autoimmune and oncology diseases and gene therapies for rare diseases. The company recently announced a...
Researchers have joined forces to design using artificial intelligence and produce next-generation viral particles to be applied in advanced therapies. These particles can be used in immunotherapies, ...
Integra Therapeutics, a global leader in creating next-generation gene writing tools to make advanced therapies safer and more effective, will present positive data from ex vivo and in vivo preclinica...